Yamamoto Mikio | Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
スポンサーリンク
概要
関連著者
-
Yamamoto Mikio
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Abe Mitsuhiro
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Nagura Jun
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Konno Fukio
Pharmaceutical Research Center Meiji Seika Kaisha
-
Yasuda Sumie
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Hui Chen
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Hachisu Mitsugu
Pharmaceutial Research Center, Meiji Kaisha, LTD.
-
Yoshida Takuji
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Konno Fukio
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Ajito Keiichi
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Kumura Ko
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Fushimi Hideki
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Hachisu Mitsugu
Pharmaceutical Research Center Meiji Seika Kaisha
-
Hachisu Mitsugu
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
HUI Chen
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
YAMAMOTO Mikio
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
YASUDA Sumie
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
Watanabe Takashi
Pharmaceutical Research Center Meiji Seika Kaisha
-
Hirai Yoko
Pharmaceutical Research Center Meiji Seika Pharma
-
UEDA Kazutaka
Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd.
-
WAKIYAMA Yoshinari
Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd.
-
UMEMURA Eijiro
Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd.
-
MASAKI Satomi
Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd.
著作論文
- ME3221, a Surmountable Angiotensin AT_1-Receptor Antagonist, Prevents Hypertensive Complications in Aged Stroke-Prone Spontaneously Hypertensive Rats
- Effects of Chronic Treatment with ME3221 on Blood Pressure and Hypertensive Complications in Aged Stroke-Prone Spontaneously Hypertensive Rats
- Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities